OncoCyte

$5.48
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.07 (+1.49%) Today

+$0.72 (+15.13%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell OncoCyte and other stocks, options, and ETFs commission-free!

About OCX

OncoCyte Corporation, also called OncoCyte, is a pharmaceutical company. It is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company was founded in September 2009 and is headquartered in Alameda, CA. The listed name for OCX is OncoCyte Corporation.

CEO

Ronald Asbury Andrews

Employees

Headquarters

Irvine, California

Founded

2009

Market Cap

281.21M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.73M

High Today

$4.91

Low Today

$4.52

Open Price

$4.58

Volume

1.91M

52 Week High

$4.92

52 Week Low

$1.15

Collections

Analyst Ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

OCX Earnings

-$0.15

-$0.10

-$0.05

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 25, After Hours